Impulsamos empresas que
proyectan el cambio
proyectan el cambio
t
t@CaixaCR
- 📷We are happy to announce that #Minoryx has achieved positive results in the #NEUX registration study of #leriglitazone for the treatment of pediatric patients with cerebral adrenoleukodystrophy #cALD 💊. See the results 👉 https://t.co/d9SQMZzAF1 @AANmember https://t.co/59ObFAIAcH
- 🗣️Exciting news!🤝Our portfolio company @TravelC_online has been acquired by @Travelsoft, to become the booking platform leader and main consolidator of the Travel industry.🙌 We are proud to have been part of this journey https://t.co/uUOKMYEKMY #TRAVELtech #travelindustry #SaaS https://t.co/9lhI2CVbeD
- 🗣️If you're an #NLP practitioner looking for a powerful, easy-to-use tool for #DataLabeling and iterating on NLP data, we invite you to check out @argilla_io on the @huggingface. You'll be impressed with the speed and accuracy of the data labeling process👉https://t.co/QlVLsU1z1w https://t.co/EeErAbAr8T
N
Noticias y eventos
(English) Caixa Capital Risc exits Travel Compositor, which joins European leader Travelsoft
10.05.2023
Travel Compositor, the leading platform in Southern Europe's markets, has joined Travelsoft, the SaaS/Travel leader in Europe. Caixa Capital Risc and the remaining investors who participated in Travel Compositor's fundraising round in 2016 have successfully exited.
Otras noticias Ver todas las noticias »
-
(English) Caixa Capital Risc leads €5.5M Series A funding round for Zinklar
13.07.2022
Caixa Capital Risc, Zinklar’s main VC shareholder, has supported the market research startup since 2017, participating in all investment rounds with total inves... -
(English) Caixa Capital Risc leads Barbara IoT €2.5 M financing round
18.05.2022
Caixa Capital Risc joins forces with Iberdrola in new funding round, enabling edge computing start-up to expand activities in Europe Investment is aligned wit... -
(English) Caixa Capital Risc leads sale of Sanifit Therapeutics to Vifor Pharma with upfront payment of €205M
24.11.2021
• Largest acquisition in history of Spanish biotechnology sector and largest operation to date for Caixa Capital Risc • Holding 20% of the capital, Caixa Cap...